Keratin 17 testing in pancreatic cancer needle aspiration biopsies predicts survival.

Lucia Roa-PeñaSruthi BabuCindy V LeitonMaoxin WuSofia TaboadaAli AkalinJonathan BuscagliaLuisa F Escobar-HoyosKenneth R Shroyer

Published in: Cancer cytopathology (2021)

K17 has been identified as a robust and independent prognostic biomarker that stratifies clinical outcomes for cases that are diagnosed by NAB. Testing for K17 also has the potential to inform clinical decisions for optimization of chemotherapeutic interventions.

Keyphrases

ultrasound guided
physical activity
advanced non small cell lung cancer
human health
climate change